In response to the threat of tariffs, Roche has committed to investing $50 billion in drug manufacturing in the United States.
Roche has announced a $50 billion investment over five years to enhance its manufacturing capabilities in the U.S., joining other major drugmakers like Johnson & Johnson and Eli Lilly in